These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19204268)

  • 1. Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation.
    Whittaker RG; Blackwood JK; Alston CL; Blakely EL; Elson JL; McFarland R; Chinnery PF; Turnbull DM; Taylor RW
    Neurology; 2009 Feb; 72(6):568-9. PubMed ID: 19204268
    [No Abstract]   [Full Text] [Related]  

  • 2. The non-syndromic clinical spectrums of mtDNA 3243A>G mutation.
    Shen X; Du A
    Neurosciences (Riyadh); 2021 Apr; 26(2):128-133. PubMed ID: 33814365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial retinal dystrophy associated with the m.3243A>G mutation.
    de Laat P; Smeitink JAM; Janssen MCH; Keunen JEE; Boon CJF
    Ophthalmology; 2013 Dec; 120(12):2684-2696. PubMed ID: 23806424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation.
    de Laat P; Rodenburg RJ; Smeitink JAM; Janssen MCH
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00523. PubMed ID: 30516030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.
    Grady JP; Pickett SJ; Ng YS; Alston CL; Blakely EL; Hardy SA; Feeney CL; Bright AA; Schaefer AM; Gorman GS; McNally RJ; Taylor RW; Turnbull DM; McFarland R
    EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29735722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATF5, a putative therapeutic target for the mitochondrial DNA 3243A > G mutation-related disease.
    Gao X; Jiang Z; Yan X; Liu J; Li F; Liu P; Li J; Wei Y; Sun YE; Zhang Y; Wang C
    Cell Death Dis; 2021 Jul; 12(7):701. PubMed ID: 34262025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of low levels of the mitochondrial tRNALeu(UUR) 3243A>G mutation in blood derived from patients with diabetes.
    Procaccio V; Neckelmann N; Paquis-Flucklinger V; Bannwarth S; Jimenez R; Davila A; Poole JC; Wallace DC
    Mol Diagn Ther; 2006; 10(6):381-9. PubMed ID: 17154655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination.
    Ng YS; Feeney C; Schaefer AM; Holmes CE; Hynd P; Alston CL; Grady JP; Roberts M; Maguire M; Bright A; Taylor RW; Yiannakou Y; McFarland R; Turnbull DM; Gorman GS
    Ann Neurol; 2016 Nov; 80(5):686-692. PubMed ID: 27453452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m.3244G>A mutation in mtDNA is another cause of progressive external ophthalmoplegia.
    Sotiriou E; Coku J; Tanji K; Huang HB; Hirano M; DiMauro S
    Neuromuscul Disord; 2009 Apr; 19(4):297-9. PubMed ID: 19285865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining Mitochondrial 3243A>G Heteroplasmy Using an ARMS-ddPCR Strategy.
    Xu P; Jia M; Yan J; Yuan X; Yu W; Zhou Z; Fang H; Gao F; Shen L
    Am J Clin Pathol; 2022 May; 157(5):664-677. PubMed ID: 34698344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced myalgia and rhabdomyolysis in a patient with the rare m.3243A>T mtDNA mutation.
    Czell D; Abicht A; Hench J; Weber M
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23220830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.
    Chin J; Marotta R; Chiotis M; Allan EH; Collins SJ
    Mitochondrion; 2014 Jul; 17():34-41. PubMed ID: 24846800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation.
    de Laat P; Koene S; van den Heuvel LP; Rodenburg RJ; Janssen MC; Smeitink JA
    J Inherit Metab Dis; 2012 Nov; 35(6):1059-69. PubMed ID: 22403016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation and diagnosis of pathogenic mitochondrial DNA mutations in human urothelial cells.
    Blackwood JK; Whittaker RG; Blakely EL; Alston CL; Turnbull DM; Taylor RW
    Biochem Biophys Res Commun; 2010 Mar; 393(4):740-5. PubMed ID: 20171163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national perspective on prenatal testing for mitochondrial disease.
    Nesbitt V; Alston CL; Blakely EL; Fratter C; Feeney CL; Poulton J; Brown GK; Turnbull DM; Taylor RW; McFarland R
    Eur J Hum Genet; 2014 Nov; 22(11):1255-9. PubMed ID: 24642831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homoplasmy, heteroplasmy, and mitochondrial dystonia.
    McFarland R; Chinnery PF; Blakely EL; Schaefer AM; Morris AA; Foster SM; Tuppen HA; Ramesh V; Dorman PJ; Turnbull DM; Taylor RW
    Neurology; 2007 Aug; 69(9):911-6. PubMed ID: 17724295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA mutation m.3243A>G is associated with altered mitochondrial function in peripheral blood mononuclear cells, with heteroplasmy levels and with clinical phenotypes.
    Geng X; Zhang Y; Yan J; Chu C; Gao F; Jiang Z; Zhang X; Chen Y; Wei X; Feng Y; Lu H; Wang C; Zeng F; Jia W
    Diabet Med; 2019 Jun; 36(6):776-783. PubMed ID: 30536471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and progression of diabetes in mitochondrial disease.
    Whittaker RG; Schaefer AM; McFarland R; Taylor RW; Walker M; Turnbull DM
    Diabetologia; 2007 Oct; 50(10):2085-9. PubMed ID: 17653689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ptosis as an associated finding in maternally inherited diabetes and deafness.
    Robberecht K; Decock C; Stevens A; Seneca S; De Bleecker J; Leroy BP
    Ophthalmic Genet; 2010 Dec; 31(4):240-3. PubMed ID: 21067488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of mitochondrial diabetes associated with 3243 bp tRNA(Leu(UUR)) mutation with few complications, regardless of 16-year disease duration.
    Suzuki Y; Atumi Y; Matsuoka K; Taniyama M; Shigeo O
    Diabetes Res Clin Pract; 2005 Sep; 69(3):309-10. PubMed ID: 15913828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.